Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ares Trading
Aubonne, Vaud, Switzerland
- Ownership
- Private
- Employees
- ~826
- Development stage
- Other
01
Overview
Ares Trading (Merck KGaA subsidiary) developed and commercialized products such as Bavencio (avelumab, a PD-L1 antibody in partnership with Pfizer, approved for multiple oncology indications) and markets fertility, oncology, neurology, and specialty therapeutics. The company licenses recombinant, biologic, and antibody technologies from academic and industry partners. It recently expanded biologicals marketing in China through collaborations with local biotech firms.
- Therapeutic areas
- OncologyNeurologyEndocrinologyOther
- Modalities
- Monoclonal antibodyBispecific monoclonal antibodyRecombinant proteinSmall moleculeBiologic
- Industry
- Pharma
02
Partnerships
Dyax (now Takeda) (antibody licensing and discovery)Zelgen Biopharmaceuticals (China marketing/licensing)F-Star (bispecific antibody licensing)Pfizer (co-commercialization of Bavencio)
Beyond the preview
Go deeper on Ares Trading.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ares Trading.